Jeanne Freddura

Corporate Officer/Principal bei COMMUNITY REDEVELOPMENT INC.

Consumer Services

Finance

Health Technology

Aktive Positionen von Jeanne Freddura

Unternehmen	Position	Beginn	Ende
COMMUNITY REDEVELOPMENT INC.	Corporate Officer/Principal	02.02.2022	-

Unternehmen	Position	Beginn	Ende
Syntimmune, Inc. Syntimmune, Inc. BiotechnologyHealth Technology Syntimmune, Inc. engages in the research and development of therapeutics for autoimmune diseases based on neonatal Fc receptor biology. Its pipeline include SYNT001 which has target indication for dermatology, hematology, and neurology. It also focuses on pre-clinical investigation of SYTN002 and related compounds such as peptide mimetics. The company was founded by Laurence J. Blumberg and Richard S. Blumberg in 2013 and is headquartered in Boston, MA.	Comptroller/Controller/Auditor	-	-

Cambridge College	Undergraduate Degree
Harvard University	Graduate Degree

International

Vereinigte Staaten

Operativ

Corporate Officer/Principal	1
Comptroller/Controller/Auditor	1
Undergraduate Degree	1

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
COMMUNITY REDEVELOPMENT INC.	Finance

Private Unternehmen	1
Syntimmune, Inc. Syntimmune, Inc. BiotechnologyHealth Technology Syntimmune, Inc. engages in the research and development of therapeutics for autoimmune diseases based on neonatal Fc receptor biology. Its pipeline include SYNT001 which has target indication for dermatology, hematology, and neurology. It also focuses on pre-clinical investigation of SYTN002 and related compounds such as peptide mimetics. The company was founded by Laurence J. Blumberg and Richard S. Blumberg in 2013 and is headquartered in Boston, MA.	Health Technology

Private Unternehmen

Health Technology